The US injection pen market is anticipated to grow at a CAGR of 6.1% over the forecast period. The key factors that primarily drives the market include the presence of a large pool of players operating in the market. Eli Lily & Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., Becton, Dickinson & Co., Novo Nordisk A/S, and AstraZeneca Plc are some of the key players operating in the US injection pen industry. These players are adopting different growth strategies such as product launch, partnership, and collaboration among others to remain competitive in the market place.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-injection-pen-market
For instance, in February 2019, Novo Nordisk partnered with Abbott Laboratories for the development of novel and smart insulin pens. Novo Nordisk announced to integrate its smart insulin pens with Abbott’s continuous glucose monitoring (CGM) systems. The company’s NovoPen 6 and NovoPen Echo Plus pre-filled, reusable, connected pens will integrate with Abbott's FreeStyle Libre's mobile app and cloud-based system to share insulin dosing data.
Further, in June 2018, AbbVie partnered with Eisai along with EA Pharma (its gastrointestinal disease unit) for the launch of an auto-injection delivery pen for Humira drug. The auto-injector system is available in two variants of 0.4ml pen to deliver 40mg Humira subcutaneously and 0.8ml for 80mg dose.
Moreover, there is an increased burden of patients suffering from diabetes, growth hormone therapy, autoimmune disorders among others; along with the increased adoption of injection pens as a homecare treatment therapy and a rise in the prevalence of chronic diseases. Such factors altogether create a wide scope for the growth of the US injection pen market over the forecast period.
Market Coverage
- Market number available for – 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segment Covered- By Type and By Disorder Type
- Country Covered- US
- Competitive Landscape- Eli Lily & Co., Pfizer Inc., Becton, Dickinson & Co., AstraZeneca Plc, and Novo Nordisk A/S
Key questions addressed by the report
- What is the market growth rate?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
US Injection Pen Market – Segmentation
By Type
- Reusable
- Disposable
By Disorder Type
- Autoimmune Disorders
- Hormonal Disorders
- Orphan Diseases
- Others
A full report of US Injection Pen Market is available at: https://www.omrglobal.com/industry-reports/us-injection-pen-market
Company Profiles
- AstraZeneca Plc
- Becton, Dickinson & Co.
- Copernicus
- Eli Lilly and Co.
- Hoffmann-La Roche Ltd.
- Gerresheimer AG
- GlaxoSmithKline Plc
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research